PharmaResearch reported consolidated operating profit of 62.63 billion won ($46.7 million) for the third quarter, up 1.2 percent from a year earlier, the company disclosed Friday.

Revenue for the same period rose 26.7 percent to 171.54 billion won.

Net profit for the period came in at 30.23 billion won, down 40.5 percent, according to preliminary figures.


jiyoon436@heraldcorp.com